Letter to the editor on 'Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small cell lung cancer'

K Park¹, J-M Sun²

Affiliations

¹ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: tntntn3@gmail.com.

Free article

Comment

K Park et al. Ann Oncol. 2014 Sep.

Free article

. 2014 Sep;25(9):1866.

doi: 10.1093/annonc/mdu244. Epub 2014 Jul 15.

K Park¹, J-M Sun²

¹ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: tntntn3@gmail.com.

No abstract available

Comment on

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
Sun JM, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, Lee DH, Pyo H, Song SY, Jung SH, Jo JS, Jo J, Sohn HJ, Suh C, Lee JS, Kim SW, Park K. Sun JM, et al. Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16. Ann Oncol. 2013. PMID: 23592701 Clinical Trial.
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
Lueza B, Le Péchoux C, Pignon JP. Lueza B, et al. Ann Oncol. 2014 Sep;25(9):1865-1866. doi: 10.1093/annonc/mdu221. Epub 2014 Jun 11. Ann Oncol. 2014. PMID: 24920790 No abstract available.